The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Hänscheid, S Hilliger… - European Journal of …, 2005 - Springer
Purpose In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Methods Fifty-four patients …
被引用次数：14 相关文章

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Hänscheid, S Hilliger… - 2005 - pubmed.ncbi.nlm.nih.gov
Purpose In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Methods Fifty-four patients …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy.

P Schneider, J Biko, H Hänscheid… - European Journal of …, 2005 - europepmc.org
Purpose In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Methods Fifty-four patients …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Hänscheid… - … Journal of Nuclear …, 2005 - search.proquest.com
Original article Page 1 The route of administration (oral vs intravenous) does not influence dose
or outcome in Graves’ disease and unifocal autonomy Peter Schneider, Johannes Biko …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Hänscheid, S Hilliger… - European Journal of …, 2005 - infona.pl
PurposeIn a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. MethodsFifty-four patients …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Haenscheid, S Hilliger… - European Journal of …, 2005 - osti.gov
In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Fifty-four patients suffering …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy.

P Schneider, J Biko, H Hänscheid… - … Journal of Nuclear …, 2005 - search.ebscohost.com
Purpose: In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Methods: Fifty-four patients …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Haenscheid, S Hilliger… - European Journal of …, 2005 - inis.iaea.org
[en] In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Fifty-four patients suffering …

The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy.

P Schneider, J Biko, H Hänscheid… - … Journal of Nuclear …, 2005 - search.ebscohost.com
Purpose: In a prospective randomised study, we investigated the influence of the route of
administration of radioiodide on dosimetry and therapy outcome. Methods: Fifty-four patients …

[引用][C] The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy

P Schneider, J Biko, H Hänscheid, S Hilliger… - European Journal of …, 2005 - Springer